Evidence map›Paper›PMID 42587845›Full record

ArticleFoods (Basel, Switzerland)2026

Prevalence and Genomic Insight of Extended-Spectrum β-Lactamase-Producing

Shahad Alsubaie, Amani T Alsufyani, Norah Alotaibi, Ashwaq Alhamed, Shahad Alsalman, Manal Almusa, Ahmad Aljohani, Amal Sabour, Lenah Mukhtar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shahad AlsubaieCollege of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Amani T AlsufyaniSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Norah AlotaibiSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Ashwaq AlhamedSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Shahad AlsalmanSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Manal AlmusaSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Ahmad AljohaniSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.ORCID 0000-0002-4467-1485
Amal SabourCollege of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-8579-9362
Lenah MukhtarSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.

Funding

Saudi Food and Drug Authority (SFDA)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial resistanceEnterobacteriaceaeextended-spectrum β-lactamase (ESBL)foodborne bacteriafood safety surveillanceSalmonella InfantisSaudi Arabiawhole-genome sequencing

Identifiers

PMID42587845
PMCPMC13464317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.